Report Cover

Global and China Precision Cancer Tests Market Size, Status and Forecast 2021-2027


Global Precision Cancer Tests Scope and Market Size
Precision Cancer Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
    Imaging
    In Vitro Diagnostic
    Others

Segment by Application
    Cancer Research Centers
    Cancer Hospital
    Surgical Centers
    Clinics
    Others

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

By Company
    Abbott
    BD
    Bio-Rad
    Cynvenio Biosystems
    Foundation Medicine
    Genomic Health
    Illumina
    Myriad Genetics
    NanoString Technologies
    QIAGEN
    Randox Laboratories
    Roche
    Philips
    Thermo Fisher Scientific
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Precision Cancer Tests Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Imaging
        1.2.3 In Vitro Diagnostic
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Precision Cancer Tests Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Cancer Research Centers
        1.3.3 Cancer Hospital
        1.3.4 Surgical Centers
        1.3.5 Clinics
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Precision Cancer Tests Market Perspective (2016-2027)
    2.2 Precision Cancer Tests Growth Trends by Regions
        2.2.1 Precision Cancer Tests Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Precision Cancer Tests Historic Market Share by Regions (2016-2021)
        2.2.3 Precision Cancer Tests Forecasted Market Size by Regions (2022-2027)
    2.3 Precision Cancer Tests Industry Dynamic
        2.3.1 Precision Cancer Tests Market Trends
        2.3.2 Precision Cancer Tests Market Drivers
        2.3.3 Precision Cancer Tests Market Challenges
        2.3.4 Precision Cancer Tests Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Precision Cancer Tests Players by Revenue
        3.1.1 Global Top Precision Cancer Tests Players by Revenue (2016-2021)
        3.1.2 Global Precision Cancer Tests Revenue Market Share by Players (2016-2021)
    3.2 Global Precision Cancer Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Precision Cancer Tests Revenue
    3.4 Global Precision Cancer Tests Market Concentration Ratio
        3.4.1 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Tests Revenue in 2020
    3.5 Precision Cancer Tests Key Players Head office and Area Served
    3.6 Key Players Precision Cancer Tests Product Solution and Service
    3.7 Date of Enter into Precision Cancer Tests Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Tests Breakdown Data by Type
    4.1 Global Precision Cancer Tests Historic Market Size by Type (2016-2021)
    4.2 Global Precision Cancer Tests Forecasted Market Size by Type (2022-2027)

5 Precision Cancer Tests Breakdown Data by Application
    5.1 Global Precision Cancer Tests Historic Market Size by Application (2016-2021)
    5.2 Global Precision Cancer Tests Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Precision Cancer Tests Market Size (2016-2027)
    6.2 North America Precision Cancer Tests Market Size by Type
        6.2.1 North America Precision Cancer Tests Market Size by Type (2016-2021)
        6.2.2 North America Precision Cancer Tests Market Size by Type (2022-2027)
        6.2.3 North America Precision Cancer Tests Market Size by Type (2016-2027)
    6.3 North America Precision Cancer Tests Market Size by Application
        6.3.1 North America Precision Cancer Tests Market Size by Application (2016-2021)
        6.3.2 North America Precision Cancer Tests Market Size by Application (2022-2027)
        6.3.3 North America Precision Cancer Tests Market Size by Application (2016-2027)
    6.4 North America Precision Cancer Tests Market Size by Country
        6.4.1 North America Precision Cancer Tests Market Size by Country (2016-2021)
        6.4.2 North America Precision Cancer Tests Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Precision Cancer Tests Market Size (2016-2027)
    7.2 Europe Precision Cancer Tests Market Size by Type
        7.2.1 Europe Precision Cancer Tests Market Size by Type (2016-2021)
        7.2.2 Europe Precision Cancer Tests Market Size by Type (2022-2027)
        7.2.3 Europe Precision Cancer Tests Market Size by Type (2016-2027)
    7.3 Europe Precision Cancer Tests Market Size by Application
        7.3.1 Europe Precision Cancer Tests Market Size by Application (2016-2021)
        7.3.2 Europe Precision Cancer Tests Market Size by Application (2022-2027)
        7.3.3 Europe Precision Cancer Tests Market Size by Application (2016-2027)
    7.4 Europe Precision Cancer Tests Market Size by Country
        7.4.1 Europe Precision Cancer Tests Market Size by Country (2016-2021)
        7.4.2 Europe Precision Cancer Tests Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Precision Cancer Tests Market Size (2016-2027)
    8.2 Asia-Pacific Precision Cancer Tests Market Size by Type
        8.2.1 Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Precision Cancer Tests Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2027)
    8.3 Asia-Pacific Precision Cancer Tests Market Size by Application
        8.3.1 Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Precision Cancer Tests Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2027)
    8.4 Asia-Pacific Precision Cancer Tests Market Size by Region
        8.4.1 Asia-Pacific Precision Cancer Tests Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Precision Cancer Tests Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Precision Cancer Tests Market Size (2016-2027)
    9.2 Latin America Precision Cancer Tests Market Size by Type
        9.2.1 Latin America Precision Cancer Tests Market Size by Type (2016-2021)
        9.2.2 Latin America Precision Cancer Tests Market Size by Type (2022-2027)
        9.2.3 Latin America Precision Cancer Tests Market Size by Type (2016-2027)
    9.3 Latin America Precision Cancer Tests Market Size by Application
        9.3.1 Latin America Precision Cancer Tests Market Size by Application (2016-2021)
        9.3.2 Latin America Precision Cancer Tests Market Size by Application (2022-2027)
        9.3.3 Latin America Precision Cancer Tests Market Size by Application (2016-2027)
    9.4 Latin America Precision Cancer Tests Market Size by Country
        9.4.1 Latin America Precision Cancer Tests Market Size by Country (2016-2021)
        9.4.2 Latin America Precision Cancer Tests Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Precision Cancer Tests Market Size (2016-2027)
    10.2 Middle East & Africa Precision Cancer Tests Market Size by Type
        10.2.1 Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Precision Cancer Tests Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2027)
    10.3 Middle East & Africa Precision Cancer Tests Market Size by Application
        10.3.1 Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Precision Cancer Tests Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2027)
    10.4 Middle East & Africa Precision Cancer Tests Market Size by Country
        10.4.1 Middle East & Africa Precision Cancer Tests Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Precision Cancer Tests Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Precision Cancer Tests Introduction
        11.1.4 Abbott Revenue in Precision Cancer Tests Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 BD
        11.2.1 BD Company Details
        11.2.2 BD Business Overview
        11.2.3 BD Precision Cancer Tests Introduction
        11.2.4 BD Revenue in Precision Cancer Tests Business (2016-2021)
        11.2.5 BD Recent Development
    11.3 Bio-Rad
        11.3.1 Bio-Rad Company Details
        11.3.2 Bio-Rad Business Overview
        11.3.3 Bio-Rad Precision Cancer Tests Introduction
        11.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2016-2021)
        11.3.5 Bio-Rad Recent Development
    11.4 Cynvenio Biosystems
        11.4.1 Cynvenio Biosystems Company Details
        11.4.2 Cynvenio Biosystems Business Overview
        11.4.3 Cynvenio Biosystems Precision Cancer Tests Introduction
        11.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2016-2021)
        11.4.5 Cynvenio Biosystems Recent Development
    11.5 Foundation Medicine
        11.5.1 Foundation Medicine Company Details
        11.5.2 Foundation Medicine Business Overview
        11.5.3 Foundation Medicine Precision Cancer Tests Introduction
        11.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2016-2021)
        11.5.5 Foundation Medicine Recent Development
    11.6 Genomic Health
        11.6.1 Genomic Health Company Details
        11.6.2 Genomic Health Business Overview
        11.6.3 Genomic Health Precision Cancer Tests Introduction
        11.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2016-2021)
        11.6.5 Genomic Health Recent Development
    11.7 Illumina
        11.7.1 Illumina Company Details
        11.7.2 Illumina Business Overview
        11.7.3 Illumina Precision Cancer Tests Introduction
        11.7.4 Illumina Revenue in Precision Cancer Tests Business (2016-2021)
        11.7.5 Illumina Recent Development
    11.8 Myriad Genetics
        11.8.1 Myriad Genetics Company Details
        11.8.2 Myriad Genetics Business Overview
        11.8.3 Myriad Genetics Precision Cancer Tests Introduction
        11.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2016-2021)
        11.8.5 Myriad Genetics Recent Development
    11.9 NanoString Technologies
        11.9.1 NanoString Technologies Company Details
        11.9.2 NanoString Technologies Business Overview
        11.9.3 NanoString Technologies Precision Cancer Tests Introduction
        11.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2016-2021)
        11.9.5 NanoString Technologies Recent Development
    11.10 QIAGEN
        11.10.1 QIAGEN Company Details
        11.10.2 QIAGEN Business Overview
        11.10.3 QIAGEN Precision Cancer Tests Introduction
        11.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2016-2021)
        11.10.5 QIAGEN Recent Development
    11.11 Randox Laboratories
        11.11.1 Randox Laboratories Company Details
        11.11.2 Randox Laboratories Business Overview
        11.11.3 Randox Laboratories Precision Cancer Tests Introduction
        11.11.4 Randox Laboratories Revenue in Precision Cancer Tests Business (2016-2021)
        11.11.5 Randox Laboratories Recent Development
    11.12 Roche
        11.12.1 Roche Company Details
        11.12.2 Roche Business Overview
        11.12.3 Roche Precision Cancer Tests Introduction
        11.12.4 Roche Revenue in Precision Cancer Tests Business (2016-2021)
        11.12.5 Roche Recent Development
    11.13 Philips
        11.13.1 Philips Company Details
        11.13.2 Philips Business Overview
        11.13.3 Philips Precision Cancer Tests Introduction
        11.13.4 Philips Revenue in Precision Cancer Tests Business (2016-2021)
        11.13.5 Philips Recent Development
    11.14 Thermo Fisher Scientific
        11.14.1 Thermo Fisher Scientific Company Details
        11.14.2 Thermo Fisher Scientific Business Overview
        11.14.3 Thermo Fisher Scientific Precision Cancer Tests Introduction
        11.14.4 Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2016-2021)
        11.14.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Precision Cancer Tests Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Imaging Table 3. Key Players of In Vitro Diagnostic Table 4. Key Players of Others Table 5. Global Precision Cancer Tests Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Precision Cancer Tests Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Precision Cancer Tests Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Precision Cancer Tests Market Share by Regions (2016-2021) Table 9. Global Precision Cancer Tests Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Precision Cancer Tests Market Share by Regions (2022-2027) Table 11. Precision Cancer Tests Market Trends Table 12. Precision Cancer Tests Market Drivers Table 13. Precision Cancer Tests Market Challenges Table 14. Precision Cancer Tests Market Restraints Table 15. Global Precision Cancer Tests Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Precision Cancer Tests Market Share by Players (2016-2021) Table 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2020) Table 18. Ranking of Global Top Precision Cancer Tests Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Precision Cancer Tests Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Precision Cancer Tests Product Solution and Service Table 22. Date of Enter into Precision Cancer Tests Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 25. Global Precision Cancer Tests Revenue Market Share by Type (2016-2021) Table 26. Global Precision Cancer Tests Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Precision Cancer Tests Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Precision Cancer Tests Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Precision Cancer Tests Revenue Market Share by Application (2016-2021) Table 30. Global Precision Cancer Tests Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Precision Cancer Tests Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 33. North America Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million) Table 35. North America Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Precision Cancer Tests Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Precision Cancer Tests Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Precision Cancer Tests Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Precision Cancer Tests Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Precision Cancer Tests Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Precision Cancer Tests Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Precision Cancer Tests Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Precision Cancer Tests Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbott Company Details Table 63. Abbott Business Overview Table 64. Abbott Precision Cancer Tests Product Table 65. Abbott Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 66. Abbott Recent Development Table 67. BD Company Details Table 68. BD Business Overview Table 69. BD Precision Cancer Tests Product Table 70. BD Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 71. BD Recent Development Table 72. Bio-Rad Company Details Table 73. Bio-Rad Business Overview Table 74. Bio-Rad Precision Cancer Tests Product Table 75. Bio-Rad Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 76. Bio-Rad Recent Development Table 77. Cynvenio Biosystems Company Details Table 78. Cynvenio Biosystems Business Overview Table 79. Cynvenio Biosystems Precision Cancer Tests Product Table 80. Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 81. Cynvenio Biosystems Recent Development Table 82. Foundation Medicine Company Details Table 83. Foundation Medicine Business Overview Table 84. Foundation Medicine Precision Cancer Tests Product Table 85. Foundation Medicine Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 86. Foundation Medicine Recent Development Table 87. Genomic Health Company Details Table 88. Genomic Health Business Overview Table 89. Genomic Health Precision Cancer Tests Product Table 90. Genomic Health Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 91. Genomic Health Recent Development Table 92. Illumina Company Details Table 93. Illumina Business Overview Table 94. Illumina Precision Cancer Tests Product Table 95. Illumina Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 96. Illumina Recent Development Table 97. Myriad Genetics Company Details Table 98. Myriad Genetics Business Overview Table 99. Myriad Genetics Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 100. Myriad Genetics Recent Development Table 101. NanoString Technologies Company Details Table 102. NanoString Technologies Business Overview Table 103. NanoString Technologies Precision Cancer Tests Product Table 104. NanoString Technologies Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 105. NanoString Technologies Recent Development Table 106. QIAGEN Company Details Table 107. QIAGEN Business Overview Table 108. QIAGEN Precision Cancer Tests Product Table 109. QIAGEN Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 110. QIAGEN Recent Development Table 111. Randox Laboratories Company Details Table 112. Randox Laboratories Business Overview Table 113. Randox Laboratories Precision Cancer Tests Product Table 114. Randox Laboratories Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 115. Randox Laboratories Recent Development Table 116. Roche Company Details Table 117. Roche Business Overview Table 118. Roche Precision Cancer Tests Product Table 119. Roche Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 120. Roche Recent Development Table 121. Philips Company Details Table 122. Philips Business Overview Table 123. Philips Precision Cancer Tests Product Table 124. Philips Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 125. Philips Recent Development Table 126. Thermo Fisher Scientific Company Details Table 127. Thermo Fisher Scientific Business Overview Table 128. Thermo Fisher Scientific Precision Cancer Tests Product Table 129. Thermo Fisher Scientific Revenue in Precision Cancer Tests Business (2016-2021) & (US$ Million) Table 130. Thermo Fisher Scientific Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Precision Cancer Tests Market Share by Type: 2020 VS 2027 Figure 2. Imaging Features Figure 3. In Vitro Diagnostic Features Figure 4. Others Features Figure 5. Global Precision Cancer Tests Market Share by Application: 2020 VS 2027 Figure 6. Cancer Research Centers Case Studies Figure 7. Cancer Hospital Case Studies Figure 8. Surgical Centers Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Precision Cancer Tests Report Years Considered Figure 12. Global Precision Cancer Tests Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Precision Cancer Tests Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Precision Cancer Tests Market Share by Regions: 2020 VS 2027 Figure 15. Global Precision Cancer Tests Market Share by Regions (2022-2027) Figure 16. Global Precision Cancer Tests Market Share by Players in 2020 Figure 17. Global Top Precision Cancer Tests Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Precision Cancer Tests as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Tests Revenue in 2020 Figure 19. Global Precision Cancer Tests Revenue Market Share by Type (2016-2021) Figure 20. Global Precision Cancer Tests Revenue Market Share by Type (2022-2027) Figure 21. North America Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Precision Cancer Tests Market Share by Type (2016-2027) Figure 23. North America Precision Cancer Tests Market Share by Application (2016-2027) Figure 24. North America Precision Cancer Tests Market Share by Country (2016-2027) Figure 25. United States Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Precision Cancer Tests Market Share by Type (2016-2027) Figure 29. Europe Precision Cancer Tests Market Share by Application (2016-2027) Figure 30. Europe Precision Cancer Tests Market Share by Country (2016-2027) Figure 31. Germany Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Precision Cancer Tests Market Share by Type (2016-2027) Figure 39. Asia-Pacific Precision Cancer Tests Market Share by Application (2016-2027) Figure 40. Asia-Pacific Precision Cancer Tests Market Share by Region (2016-2027) Figure 41. China Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Precision Cancer Tests Market Share by Type (2016-2027) Figure 49. Latin America Precision Cancer Tests Market Share by Application (2016-2027) Figure 50. Latin America Precision Cancer Tests Market Share by Country (2016-2027) Figure 51. Mexico Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Precision Cancer Tests Market Share by Type (2016-2027) Figure 55. Middle East & Africa Precision Cancer Tests Market Share by Application (2016-2027) Figure 56. Middle East & Africa Precision Cancer Tests Market Share by Country (2016-2027) Figure 57. Turkey Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Precision Cancer Tests Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Abbott Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 61. BD Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 62. Bio-Rad Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 63. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 64. Foundation Medicine Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 65. Genomic Health Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 66. Illumina Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 67. Myriad Genetics Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 68. NanoString Technologies Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 69. QIAGEN Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 70. Randox Laboratories Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 71. Roche Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 72. Philips Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Tests Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us